Your browser doesn't support javascript.
loading
تبين: 20 | 50 | 100
النتائج 1 - 20 de 63
المحددات
1.
Int. j. morphol ; 41(3): 699-704, jun. 2023. tab
مقالة ي الانجليزية | LILACS | ID: biblio-1514323

الملخص

SUMMARY: One of the most important minimally invasive treatments today in temporomandibular joint osteoarthritis (TMJ- OA) is the intra-articular exogenous hyaluronic acid (HA) injection, which has yielded good results in pain relief and improves mandibular function with few side effects. However, the effectiveness of HA continues to be controversial, partly due to the heterogeneity in the injection protocols in their molecular weight, viscosity and frequency of infiltration, among other properties. The aim of this review is to identify the differences in the histological and clinical effects of the different types of HA and the frequency of infiltration on TMJ-OA treatment. Materials and methods: A bibliographic search was performed in the PubMed, Web of Science and Scopus databases. The search was limited up to September 2022. Search terms included "osteoarthritis", "hyaluronic acid, "molecular weight", "concentration", "viscosity", "dose" and "temporomandibular", using AND/OR as Boolean terms. Results: Exogenous HA in its different molecular weights offers an improvement in histological and clinical characteristics. Apparently, low and medium molecular weight HA presents better results. No clinical studies related to the degree of HA viscosity were found. Respect to the frequency of infiltration, single injection, weekly injections for 3 weeks, weekly injections for 5 weeks and other protocols are used. However, their comparison is complex. There seems to be differences in the effects of the different HA preparations for the treatment of TMJ-OA, mainly in their molecular weight. However, the evidence remains scant.


Uno de los tratamientos mínimamente invasivos más importantes en la actualidad en la artrosis de la articulación temporomandibular (OATM) es la inyección intraarticular de ácido hialurónico (AH) exógeno, que ha dado buenos resultados en el alivio del dolor y mejora la función mandibular con pocos efectos secundarios. Sin embargo, la efectividad del AH continúa siendo controversial, en parte debido a la heterogeneidad en los protocolos de inyección en cuanto a su peso molecular, viscosidad y frecuencia de infiltración, entre otras propiedades. El objetivo de esta revisión fue identificar las diferencias en los efectos histológicos y clínicos de los diferentes tipos de HA y la frecuencia de infiltración en el tratamiento de TMJ-OA. Se realizó una búsqueda bibliográfica en las bases de datos PubMed, Web of Science y Scopus. La búsqueda se limitó hasta septiembre de 2022. Los términos de búsqueda incluyeron "osteoartritis", "ácido hialurónico", "peso molecular", "concentración", "viscosidad", "dosis" y "temporomandibular", utilizando AND/OR como términos booleanos. El HA exógeno en sus diferentes pesos moleculares ofrece una mejora en las características histológicas y clínicas. Aparentemente, el AH de bajo y medio peso molecular presenta mejores resultados. No se encontraron estudios clínicos relacionados con el grado de viscosidad del HA. Respecto a la frecuencia de infiltración, se utilizan inyecciones únicas, inyecciones semanales durante 3 semanas, inyecciones semanales durante 5 semanas y otros protocolos. Sin embargo, su comparación es compleja. Parece haber diferencias en los efectos de las diferentes preparaciones de HA para el tratamiento de la OA-TMJ, principalmente en su peso molecular. Sin embargo, la evidencia sigue siendo escasa.


الموضوعات
Humans , Osteoarthritis/drug therapy , Temporomandibular Joint Disorders/drug therapy , Hyaluronic Acid/administration & dosage , Viscosity/drug effects , Injections , Molecular Weight
2.
J. oral res. (Impresa) ; 10(2): 1-10, abr. 30, 2021. ilus, tab
مقالة ي الانجليزية | LILACS | ID: biblio-1382212

الملخص

Objetive: The degenerative diseases of the tempo-romandibular joint (TMJ) are characterized by a progressive destruction of the articular tissues of the condyle and the glenoid fossa. The main aim of this review is to describe the effectiveness of the hyaluronic acid (HA) in the treatment of degenerative diseases of the TMJ in accordance with the available scientific evidence. Material and Methods: A literature search was made in the following databases EBSCO, Pubmed, Cochraneand Trip Database, using the keywords hyaluronic, hyaluronan, NaH, hyaluronate, TMJ, TMD, CMD, craniomandibular, orofacial pain and temporomandibular. There were no date or language restrictions applied. Results: After applying inclusion and exclusion criteria, 14 studies were included in this review (11 randomized controlled clinical trials and 3 non-randomized clinical trials). Conclusion: The studies reported a decrease in pain and improvement in functional parameters after treatment of TMJ osteoarthritis with HA . The use of arthrocentesis associated with the administration of HA provides effects synergistic, reaching a superiority the protocols with multiple injections with respect to those of a single session. The adverse effects related to the injection of HA with or without associated arthrocentesis were minor and transitory.


Resumen: Objetivo: Las enfermedades degenerativas de la articulación temporomandibular (ATM) se caracterizan por una destrucción progresiva de tejidos articulares en el cóndilo y la fosa glenoidea. El objetivo principal de esta revisión es describir la efectividad del uso de ácido hialurónico en el tratamiento de enfermedades degenerativas de la articulación temporomandibular de acuerdo con la evidencia científica disponible. Material y Métodos: Se realizó una búsqueda de la literatura en las bases de datos electrónicas EBSCO, PubMed, Cochrane y Trip Database, utilizando las palabras claves hyaluronic, hyaluronan, NaH, hyaluronate, tmj, tmd, cmd, craniomandibular, orofacial pain y temporomandibular, sin límite de fecha ni de idioma hasta Mayo del año 2020, complementada con una búsqueda retrógrada. Resultados: Con base en los criterios de inclusión y exclusión, 14 estudios fueron incluidos en esta revisión (11 ensayos clínicos controlados aleatorizados y 3 ensayos clínicos controlados no aleatorizados). Conclusión: Los estudios reportaron una disminución del dolor y mejora en los parámetros funcionales luego del tratamiento de osteoartritis de la ATM con AH. El uso de artrocentesis asociada a la administración del AH provee efectos sinérgicos, alcanzando una superioridad los protocolos con múltiples inyecciones con respecto a aquellos de una sola sesión. Los efectos adversos relacionados con la inyección de AH con o sin artrocentesis asociada fueron menores y transitorios.


الموضوعات
Humans , Osteoarthritis/drug therapy , Temporomandibular Joint Disorders/drug therapy , Hyaluronic Acid/administration & dosage , Facial Pain , Viscosupplementation , Arthrocentesis
3.
Adv Rheumatol ; 60: 26, 2020. tab, graf
مقالة ي الانجليزية | LILACS | ID: biblio-1130806

الملخص

Abstract Background: Injection of Hylan G-F20 (HY) into joints may provoke local flares, which mechanisms may involve reaction to protein contaminants. We have previously developed a protein-free saline-soluble galactomannan derived from guar gum (GM) that displays both analgesia and chondroprotection in experimental osteoarthritis (OA). We now demonstrate that both GM and Hylan G-F20 (HY) promote mild synovitis with cytokine release after intra-articular injection. Methods: Mice received 100 μg/25 μL GM or HY or saline into the knees. Joint pain was evaluated using von Frey test; cell influx, interleukin (IL)-1, IL-6, and CXCL-1 (pg/mL) levels were assessed in joint lavage at 6 h. Synovia were excised for histopathology. Results: Neither GM nor HY after being given into mice knee joints induced pain albeit promoting mild cell influx into joint washings as well as mild synovitis at histology, with no damage to the underlying cartilage. HY but not GM promoted IL-1 release into mice joints. Both compounds induced IL-6 and CXCL-1 release. Conclusion: Intra-articular injection of HY or GM promote acute transient synovitis whilst not provoking detectable significant joint damage. Local administration of these polysaccharides induces acute intra-articular release of inflammatory cytokines, which may account for joint flares following viscosupplementation.(AU)


الموضوعات
Animals , Mice , Osteoarthritis/physiopathology , Polysaccharides/administration & dosage , Viscosupplementation/instrumentation , Hyaluronic Acid/administration & dosage
4.
J. oral res. (Impresa) ; 8(supl.1): 28-31, ago. 9, 2019. tab
مقالة ي الانجليزية | LILACS | ID: biblio-1141503

الملخص

Surgical extraction of impacted lower wisdom teeth is a frequent minor intraoral surgical process. It is regularly linked with aching and postoperative consequences as pain and swelling. The aim of this study is to evaluate the efficacy of two methods in reducing swelling and pain subsequent to the removal of impacted wisdom teeth. This randomized study incorporated 20 patients with impacted wisdom teeth of different surgical complexity. Topical hyaluronic acid gel 2g/2ml with aloe vera (Kin®Care) was given to the patients to be applied to the surgical area three times a day, or diclofenac sodium tablet 50mg (Voltaren®) to be taken every eight hours, for one week. Swelling was estimated using a strip gauge technique, and pain with a visual analogue scale. Evaluations were made on day one of surgical treatment and on 72hrs and one week later. Statistically no significant differences were identified regarding the swelling and pain values between the two treatment groups on the third and seventh day after surgery. Hyaluronic acid gel was as efficient as diclofenac tablets in reducing the two parameters. The use of hyaluronic acid may be advantageous in medically compromised patient such as those with hypertension, chronic asthma, gastric ulcers or in those with any contraindications to using non-steroidal anti-inflammatory drugs, or in pregnant patients to reduce pain and swelling subsequent to impacted wisdom teeth surgery.


الموضوعات
Humans , Male , Female , Adolescent , Adult , Young Adult , Pain, Postoperative , Tooth Extraction , Diclofenac/administration & dosage , Cicatrix/drug therapy , Hyaluronic Acid/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Molar, Third
5.
Int. braz. j. urol ; 44(6): 1200-1206, Nov.-Dec. 2018. tab, graf
مقالة ي الانجليزية | LILACS | ID: biblio-975662

الملخص

ABSTRACT Objective: To identify how many endoscopic injection (EI) procedures, STING method, must be performed before reaching an ideal success rate when simulation training has not been received. Materials and Methods: The EI procedures performed by two pediatric urology fellows were investigated. The study excluded patients without primary VUR and those with previous EI or ureteroneocystostomy, lower urinary tract dysfunction, and/or duplicate ureters. The EIs used dextranomer hyaluronate and the STING method, as described by O'Donnell and Puri. Groups number was determined by multiple statistical trials. Statistically significance differences were achieved with one combination that had 35 EI procedures each and with 3 different combination of patients, having 12, 24, and 36 patients, respectively. Therefore, groups were established 12 patients. The first fellow performed 54 EIs, and the second performed 51. Therefore, each of the first fellow's three groups contained 18 EI procedures, and each of the second fellow's 17. Results: The study included 72 patients and 105 ureter units. When the data from both fellows were combined, each of the three groups contained 35 procedures. For the first fellow, the success rates in the first, second, and third groups were 38.3%, 66.6%, and 83.3% (p = 0.02), respectively, and for the second fellow, the success rates were 41.2%, 64.7%, and 82.3% (p = 0.045), respectively. The increased success rates for both fellows were very similar. Conclusions: An acceptable rate of success for EI may be reached after about 20 procedures and a high success rate after about 35-40 procedures.


الموضوعات
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Vesico-Ureteral Reflux/therapy , Learning Curve , Hyaluronic Acid/administration & dosage , Retrospective Studies , Dextrans/administration & dosage , Treatment Outcome , Clinical Competence , Cystoscopy
6.
Int. braz. j. urol ; 44(6): 1194-1199, Nov.-Dec. 2018. tab, graf
مقالة ي الانجليزية | LILACS | ID: biblio-975658

الملخص

ABSTRACT Introduction: Various bulking agents were utilized for endoscopic correction of VUR. A study reviewing multi-institutional data showed that the amount of injection material has increased over time with the purpose of improving success rates, which also resulted in costs. We noticed an opposite trend in our center since we started using a new bulking agent. The aim of this study was to evaluate evolution of our practice with different bulking agents. Patients and Methods: Records of VUR patients who underwent subureteric injection with polyacrylate polyalcohol copolymer (PPC) and dextronomere hyaluronic acide (DxHA) between 2005 and 2014 were reviewed. Variation of different parameters throughout the study period was evaluated along with the success rate. Success was defined as complete resolution of reflux. Results: A total of 260 patients with 384 refluxing units were included. The success rate was higher in PPC group compared to DxHA group. There was no statistically significant difference between years regarding distribution of VUR grade, body weight, patient height, and age in PPC group. Despite significant reduction in injection volume, success rate did not decrease through the years with PPC. Conclusion: Different bulking agents may require different injection volumes to achieve the same success rate in endoscopic treatment of vesicoureteral reflux. Habits gained with previous experience using other materials should be revised while using a new agent.


الموضوعات
Humans , Child, Preschool , Child , Polymers/administration & dosage , Vesico-Ureteral Reflux/therapy , Biocompatible Materials/administration & dosage , Acrylic Resins/administration & dosage , Dextrans/administration & dosage , Hyaluronic Acid/administration & dosage , Follow-Up Studies , Treatment Outcome , Ureteroscopy
7.
Acta ortop. mex ; 32(2): 70-75, mar.-abr. 2018. tab, graf
مقالة ي الأسبانية | LILACS | ID: biblio-1019333

الملخص

Resumen: Objetivo: Nuestro objetivo fue evaluar la efectividad de las infiltraciones subacromiales de ácido hialurónico en el tratamiento del dolor crónico de hombro como alternativa a los tratamientos quirúrgicos y no quirúrgicos actualmente disponibles. Material y métodos: Estudio prospectivo de 80 pacientes consecutivos con dolor crónico de hombro seguidos durante 12 meses. Se realizaron cinco infiltraciones subacromiales con ácido hialurónico durante cinco semanas consecutivas y se analizaron los resultados clínicos obtenidos. Resultados: La puntuación en la escala de Constant mejoró en 7.7 puntos, el cuestionario DASH disminuyó en cinco puntos y la puntuación en la escala visual analógica para el dolor disminuyó 1.6 puntos por término medio. Los pacientes que presentaban dolor de menos de 24 meses de evolución respondieron mejor al tratamiento. Las mujeres respondieron mejor. Los pacientes con disminución del espacio subacromial o lesión del manguito rotador según la resonancia magnética mejoraron, pero los pacientes que mostraron signos de artrosis acromioclavicular en la resonancia empeoraron en todas las escalas evaluadas. Discusión: Las infiltraciones subacromiales de ácido hialurónico son especialmente efectivas en el tratamiento del dolor crónico de hombro de menos de 24 meses de evolución, con disminución del espacio subacromial o lesión parcial o total del manguito rotador, pero en nuestra experiencia, su resultado no es bueno en pacientes con artrosis acromioclavicular.


Abstract: Objective: Our purpose was to assess the effectiveness of hyaluronic acid infiltrations for chronic shoulder pain as an alternative to the non-surgical and surgical treatments that are currently available. Material and methods: This is a prospective study of 80 consecutive patients suffering from chronic shoulder pain followed for twelve months. Five subacromial hyaluronic acid injections on five consecutive weeks were administrated to all patients. Results: A significant improvement within the whole group after six months was observed. Constant score improved by 7.7 points, DASH questionnaire decreased by 5 points and Visual Analog Scale for pain decreased by 1.6 points. Patients with history of less than 24 months of pain responded better to treatment. Females responded better. Patients with decreased subacromial space or cuff tear in the MRI improved but patients diagnosed by the MRI of acromioclavicular osteoarthritis worsened in all scales assessed. Discussion: Subacromial hyaluronic acid injections are specially effective in patients with history of less than 24 months of pain, a decreased subacromial space or partial or total cuff tear but, in our experience, its result is not good in patients with acromioclavicular osteoarthritis.


الموضوعات
Humans , Male , Female , Shoulder Pain/drug therapy , Viscosupplements/administration & dosage , Hyaluronic Acid/administration & dosage , Prospective Studies , Treatment Outcome , Injections
8.
Int. j. morphol ; 35(3): 870-876, Sept. 2017. ilus
مقالة ي الانجليزية | LILACS | ID: biblio-893066

الملخص

The aim of this study was to perform a literature review regarding the role of hyaluronic acid (HA) in the homeostasis and therapeutics of temporomandibular joint (TMJ) osteoarthritis (OA). The TMJ has characteristics that give it special adaptation and recovery abilities, where HA plays a fundamental role in helping to maintain joint homeostasis, which is affected in pathological processes like OA. OA is a chronic degenerative multi-factor disease that can affect all the components of the synovial joints, causing degradation of the articular cartilage, extracellular matrix and breakage in the HA molecules. HA is a non-branched linear polysaccharide with viscosupplementation, anti-inflammatory, lubrication and pain relief effects; it also activates the intrinsic repair processes of the cartilage and normalizes the endogenous production of HA by the synoviocytes. In recent years, the therapeutic use of HA has shown evidence that supports its application in TMJ OA, improving viscosupplementation capacity, acting at the cellular and molecular levels, reducing various inflammatory mediators and improving the reparative characteristics. Its use has been studied in animal models and in humans. However, no consensus has been reached in terms of concentrations, dose, application frequency or molecular weight to be used.


El objetivo de este estudio fue realizar una revisión de la literatura respecto del rol del ácido hialurónico (AH) en la homeostasis y terapéutica de la osteoartritis (OA) de la articulación temporomandibular (ATM). La ATM presenta características que le confieren propiedades de adaptación y recuperación especiales, donde el AH juega un rol fundamental ayudando a mantener la homeostasis articular, la cual se ve afectada en procesos patológicos como la OA. La OA es una enfermedad multifactorial crónica degenerativa que puede afectar a todos los componentes de las articulaciones sinoviales, generando degradación del cartílago articular, matriz extracelular y quiebre de las moléculas de AH. El AH es un polisacárido lineal no ramificado que presenta efectos de viscosuplementación, antiinflamatorios, lubricantes, en el alivio del dolor, permite además, activar procesos intrínsecos de reparación del cartílago y normalizar la producción endógena de AH por parte de los sinoviositos. En los últimos años el uso terapéutico del AH ha presentado evidencia que sustenta su aplicación en OA de ATM mejorando la capacidad de viscosuplementación, actuando a nivel celular y molecular, disminuyendo diversos mediadores inflamatorios y mejorando las características reparativas. Su uso se ha estudiado en modelos animales y en humanos, sin embargo no existe consenso en cuanto a concentraciones, dosis, frecuencias de aplicación y peso molecular a utilizar.


الموضوعات
Osteoarthritis/drug therapy , Temporomandibular Joint Disorders/drug therapy , Viscosupplementation/methods , Hyaluronic Acid/administration & dosage , Temporomandibular Joint/drug effects , Homeostasis/drug effects
9.
Int. j. odontostomatol. (Print) ; 11(2): 157-164, June 2017. ilus
مقالة ي الأسبانية | LILACS | ID: biblio-893245

الملخص

El objetivo de este trabajo fue determinar la disminución del dolor y la mejora de la función en los procesos artrósicos de la ATM mediante el empleo de hialuronato de sodio o corticoides. Realización de una revisión sistemática conforme a la metodología PICO del Centro de Medicina Basada en la Evidencia de Oxford. Se formula una pregunta dirigida al objetivo fijado y se elabora una estrategia de búsqueda, empleando términos MeSH y palabras clave específicas derivados de la pregunta en la base de datos de MEDLINE de enero de 1985 hasta abril del 2016. Se consultan un total de 43 artículos, incluyendo finalmente 7 estudios clínicos controlados y aleatorizados que cumplían los criterios de inclusión y se realiza una evaluación crítica del nivel de evidencia. Se estudiaron trabajos que comparasen la eficacia del hialuronato de sodio con los corticoides en la inyección articular de las patologías artrósicas de la ATM. No se encontraron diferencias significativas en la realización de la inyección con hialuronato de sodio y corticoides. Es necesario realizar estudios con una muestra y un tiempo de seguimiento mayor. A largo plazo podría ser más eficaz el hialuronato de sodio debido a los posibles efectos adversos de los corticoides, sin embargo, no se han demostrado cambios óseos con ninguno de los tratamientos.


The aim of this study was to determine decreasing pain and improving function in TMJ osteoarthritic processes using sodium hyaluronate or corticosteroids. A systematic review was carried out based on the PICO methodology of the Centre for Evidence-Based Medicine in Oxford. A question is addressed to the fixed aim and a search strategy is developed using specific MeSH terms and key words which come from the question in the PubMed database from January 1985 to April 2016. A total of 43 articles are consulted, finally including 7 randomized controlled trials which met the inclusion criteria and a critical assessment of the level of evidence is performed. Works that compare the efficacy of sodium hyaluronate to corticosteroids in the osteoarthritic pathologies articular injection were studied. No significant differences were found when injecting the sodium hyaluronate and the corticosteroids. It is necessary to do studies with a broader sample and a longer follow-up. In the long term sodium hyaluronate could be more effective because of possible corticosteroids adverse effects; however, no bone change has been shown with either treatment.


الموضوعات
Humans , Temporomandibular Joint , Temporomandibular Joint Disorders , Temporomandibular Joint Dysfunction Syndrome/therapy , Osteoarthritis , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/therapeutic use , Hyaluronic Acid/administration & dosage , Hyaluronic Acid/therapeutic use
10.
Int. j. med. surg. sci. (Print) ; 3(3): 959-962, sept. 2016.
مقالة ي الأسبانية | LILACS | ID: biblio-1088105

الملخص

La osteoartritis es un tipo de trastorno temporomadibular de origen articular, siendo uno de los procesos degenerativos óseos que más comúnmente afectan a la articulación temporomandibular. Se caracteriza por remodelación del hueso subcondral subyacente, deterioro y abrasión del tejido articular. Las infiltraciones intraarticulares de ácido hialurónico se consideran beneficiosas para el tratamiento del dolor y la recuperación de propiedades de los tejidos articulares. El objetivo de éste artículo es describir el uso de ácido hialurónico en el manejo de osteoartritis de articulación temporomandibular en un paciente adolescente. Paciente de sexo femenino, 15 años de edad, presenta dolor de un año de evolución en la región preauricularbilateral, con aumento de dolor en apertura máxima. Considerando el examen clínico e imagenológico se diagnostica una luxación discal con reducción con componente osteoartritico e inflamatorio bilateral. Se indica reposo mandibular, dieta líquida, AINEs y se realiza la aplicación intraarticular de ácido hialurónico(Suprahyalâ 25 mg/2,5 ml) bilateral. Se cita a control a las 2, 3 y 16 semanas donde la paciente se encuentra sin dolor espontaneo y a la palpación. El uso de ácido hialurónico es una de las alternativas terapeúticas más utilizadas para el manejo de la osteoartritis de articulación temporomandibular, sin embargo es necesario que la evidencia de su aplicación intraarticular en adolescentes y niños se consolide.


Osteoarthritis is a type of articular origin Temporomandibular disorders, being one of themost common degenerative processes affecting thetemporomandibular joint. It is characterized byremodeling of the underlying subchondral bone,deterioration and abrasion of articular tissue. Intra-articular injections of hyaluronic acid are considered beneficial for treatment of pain and recovery of joint tissues properties. The aim of this article is to describe the use of hyaluronic acid in the management of osteoarthritis of temporomandibular joint in an adolescent patient. Female patient, 15 years old,presented pain with a year of progress in the bilateral preauricular region, with increased pain at maximum aperture. Considering the clinical and imaging tests the patient was diagnosed with disk displacement with reduction with bilateral osteoarthritic and inflammatory component. Mandibular rest, liquid diet, NSAIDs were indicated and the application of intra-articular hyaluronicacid (Suprahyalâ 25 mg / 2.5 ml) bilaterally. Control was quoted at 2, 3 and 16 weeks where the patient has no spontaneous pain and tenderness. The use of hyaluronic acid is one of the most commonly usedtherapeutic alternatives for the management ofosteoarthritis of temporomandibular joint. However,further evidence of its use in intra-articular application in adolescents and children should be incorporated.


الموضوعات
Humans , Female , Adolescent , Osteoarthritis/drug therapy , Temporomandibular Joint/drug effects , Viscosupplements/administration & dosage , Hyaluronic Acid/administration & dosage , Temporomandibular Joint Disorders/drug therapy , Viscosupplements/therapeutic use , Musculoskeletal Pain/etiology , Hyaluronic Acid/therapeutic use , Injections, Intra-Articular
11.
Lima; s.n; mar. 2016.
غير التقليدية ي الأسبانية | LILACS, BRISA | ID: biblio-848759

الملخص

INTRODUCCIÓN: Antecedentes: Las adherencias son bandas de tejido similar el tejido cicatricial que se forman entre superfícies dentro del organismo y hacen que estas se unan. Se forman más frecuentemente en el abdomen y pelvis después de cirugias intestinales o de los órganos femeninos, estas producen diversar molestias como distención o hinchazón abdominal, estreñimiento, náuseas y vomitos, incluso dolor pélvico intenso y crónico. Las adherencias son parte de un proceso fisiopatológico desencadenado o en respuesta al corte, isquemia, abrasión del peritoneo durante la cirugia. Las zonas alteradas sufren de regeneración mesotelial y fibrosis resultando en la formación de adherencias entre los tejidos serosos dañados. Las adherencias pueden tener un efecto beneficioso, ya que permite neovscularización de zonas isquémicas del intestino, tales como en las anastomosis, pero generalmente ocasionan probelmas cuando se vuelven excesivas. Las adherencias son la principal causa de obstrucción intestinal que causa el 70% de readmisiones hospitalarias. El hialuronato de sodio más carboximetilcelulosa, es descrito como un agente antiadherente no tóxico, no inmunogénico y biocompatible que reduce la incidencia y extensión de las adherencias postoperatorias. Compuesto de hialuronato de sodio y carboximetilcelulosa está modificado químicamente para retardar su tasa de degradación y deputación después de entrar en contato con el organismo. METODOLOGÍA: Se realizó una búsqueda bibliográfica de la literatura con respecto a la eficacia y seguridad del uso del Gel Antiadherencial Post quirúrgico. Se seleccionaron artículos científicos: evaluación de tecnologías santiarias, revisiones sistemáticas, met-análisis y ensayos clínicos. Se realizó una búsqueda dentro de la información generada por grupos que realizan revisiones sistemáticas, evaluación de tencologías sanitarias y guías de práctica clínica, tales como The Cochrane Library y The National Institute for Health and Care Excelence (NICE). Además, se hizo una búsqueda en www.clinicaltrials.gov, para poder identificar ensayos aún en elaboración o que no hayan sido publicados. CONCLUSIONES: Las investigaciones publicadas hasta marzo del 2016 son insuficientes para poder determinar la eficacia y seguridad del gel antiadherencial postquirúrgico (hialuronato de sodio más carboximetilcelulosa). Los resultados de los estudios preclínicos son discordantes con los ensayos clínicos realizados posteriomente. El Instituto de Tecnologías en Salud e Investigación-IETSI, no aprueba el uso del gel antiadherencial en sus presentaciones: (hialuronato de sodio más carboximetilcelulosa, alginato o la combinación de hialuronato de sodio más carboximetilcelulosa y alginato; para la reducción de adherencias abdominlaes y pélvicas.


الموضوعات
Humans , Abdomen/surgery , Hyaluronic Acid/administration & dosage , Pelvis/surgery , Alginates/administration & dosage , Carboxymethylcellulose Sodium/administration & dosage , Drug Combinations , Gels , Postoperative Care/methods , Technology Assessment, Biomedical , Tissue Adhesions/complications , Treatment Outcome
12.
Rev. otorrinolaringol. cir. cabeza cuello ; 75(3): 232-238, dic. 2015. graf
مقالة ي الأسبانية | LILACS | ID: lil-771694

الملخص

Introducción: El manejo inicial de la parálisis cordal unilateral incluye la observación en espera de la recuperación de la movilidad o la compensación, terapia fonoaudiológica o inyección de medialización temporal para llevar la cuerda a una posición más favorable para el cierre glótico. Este procedimiento puede realizarse en pabellón, o vía percutánea en paciente despierto. Existen varias opciones, siendo el ácido hialurónico (Restylane®) uno de los más usados. Objetivo: Revisar la experiencia pionera en el país en la inyección de medialización de cuerda vocal con ácido hialurónico en el manejo de la parálisis cordal unilateral. Material y método: Estudio retrospectivo, que incluyó a 15 pacientes con insuficiencia glótica a los que se les realizó una inyección percutánea con ácido hialurónico. Se evaluó la calidad de la voz pre y posprocedimiento (VRQOL), tolerancia al procedimiento y complicaciones. Resultados: El 100% de los pacientes mostró cambios significativos en el VRQOL, con un cambio promedio pre y post de 37%. El procedimiento fue bien tolerado en el 93%. No se produjeron incidentes durante la inyección ni tampoco posteriores. Conclusión: La inyección de medialización es un procedimiento bien tolerado, seguro y sencillo, que permite mejoras significativas en la calidad vocal. El ácido hialurónico es seguro y eficaz para la inyección de medialización.


Introduction: Initial treatment options for unilateral vocal fold paralysis include observation for spontaneous return of function or compensation, voice therapy to stimulate recovery of motion or function, or temporary vocal fold injection medialization to improve glottic closure. Temporary injection medialization can be performed under general anesthesia or in the awake-patient setting with local anesthesia. There are different options of temporary injection materials, being hyaluronic acid (Restylane®) one of the most popular. Aim: To review our pioneer experience in Chilewith the use of temporary vocal fold injection with hyaluronic acid in the initial management of unilateral vocal fold paralysis. Material and method: Retrospective study involving 15 patients with glottic insufficiency, who underwent percutaneous vocal fold injection medialization with hyaluronic acid. Pre and post procedure quality of voice (VRQOL), tolerance to the procedure, and complications were evaluated. Results: All patients showed significant changes in VRQOL, with a 37% average improvement. The procedure was well tolerated in 93%. No incidents occurred during injection orlater. Conclusions: The temporary vocal fold injection medialization is a well-tolerated, safe and simple procedure that allows significant short-term improvements in vocal quality of patients. Hyaluronic acid is a safe and effective material for temporary vocal foldinjection medialization.


الموضوعات
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Vocal Cord Paralysis/surgery , Vocal Cord Paralysis/drug therapy , Laryngoplasty/methods , Hyaluronic Acid/administration & dosage , Quality of Life , Injections, Intralesional , Surveys and Questionnaires , Retrospective Studies , Treatment Outcome
13.
Acta ortop. bras ; Acta ortop. bras;23(3): 162-166, May-Jun/2015. tab, graf
مقالة ي الانجليزية | LILACS | ID: lil-748142

الملخص

Objetivo: Avaliar se lavagem articular, viscossupplementação e triancinolona melhoram a dor, função e qualidade de vida de pacientes com artropatia hemofílica grave. Métodos: Quatorze pacientes com poliartrite hemofílica do joelho e/ou tornozelo com ou sem envolvimento de outras articulações foram submetidos a lavagem articular e subsequente injeção de hilano G-F20 e triancinolona em todas as articulações afetadas. Os pacientes responderam aos questionários algo funcionais (Lequesne e WOMAC), escala visual analógica parador (EVA) e SF-36 no pré-operatório, um, três, seis e 12 meses de pós-operatório. Resultados: Dezesseis joelhos, 15 tornozelos,oito cotovelos e um ombro foram tratados em 14 pacientes. Seis pacientes tiveram sangramento musculoesquelético [tornozelo (1),músculo da perna (2) e joelhos (4)] próximo da avalição de três meses afetando os resultados. A dor não melhorou significativamente.A função melhorou (WOMAC p = 0,02, Lequesne p = 0,01).O componente físico do SF-36 melhorou em todos os momentos,exceto em três meses, com melhores resultados após um ano(pré-operatório = 33.4; um mês = 39,6; três meses = 37,6; seismeses = 39,6; um ano = 44,6; p <0,001). Conclusão: A lavagem articular seguida da injeção de triancinolona e hilano G-F20 melhora a função e a qualidade de vida na artropatia hemofílica grave. Nível de Evidência IV, Série de Casos.


Objective: To assess whether joint lavage, viscosupplementation and triamcinolone improve joint pain, function and quality of life in patients with severe hemophilic arthropathy. METHODS: Fourteen patients with knee and/or ankle hemophilic arthritis with and without involvement of other joints underwent joint lavage and subsequent injection of hylan G-F20 and triamcinolone in all affected joints. The patients answered algo-functional questionnaires (Lequesne and WOMAC), visual analog scale for pain (VAS) and SF-36 preoperatively, and at one, three, six and twelve months postoperatively. RESULTS: Sixteen knees, 15 ankles, 8 elbows and one shoulder were treated in 14 patients. Six patients had musculoskeletal bleeding [ankle (1), leg muscle (2) and knees (4)] at 3 months affecting the results. Pain did not improve significantly. Function improved (WOMAC p=0.02 and Lequesne p=0.01). The physical component of SF-36 improved at all time points except at 3 months, with best results at one-year follow-up (baseline = 33.4; 1 month = 39.6; 3 months= 37.6; 6 months 39.6 and 1 year = 44.6; p < 0.001). CONCLUSION: Joint lavage followed by injection of triamcinolone and hylan G-F20 improves function and quality of life progressively up to a year, even in severe hemophilic arthropathy. Level of Evidence IV, Case Series.


الموضوعات
Humans , Ankle , Hyaluronic Acid/administration & dosage , Hyaluronic Acid/therapeutic use , Elbow , Hemophilia A , Joint Diseases , Knee , Osteoarthritis , Shoulder , Viscosupplementation
14.
Rev. chil. cir ; 67(2): 199-203, abr. 2015. ilus
مقالة ي الأسبانية | LILACS | ID: lil-745083

الملخص

Introduction: Thyroid surgery rates have tripled over the past 3 decades. Currently, the main postoperative complications of this surgery are vocal fold paralysis because of recurrent laryngeal nerve dysfunction and hypocalcemia. Case report: We report the case of a 58 years old woman who presented with persistent dysphonia post total thyroidectomy. Laryngeal videostroboscopy evidenced unilateral vocal fold paralysis. We performed a percutaneous injection laryngoplasty with hyaluronic acid achieving significant improvement in voice. Conclusions: Percutaneous injection laryngoplasty with hyaluronic acid is a safe and effective procedure in the management of post thyroidectomy vocal cord paralysis.


Introducción: La tasa de cirugía tiroidea se ha triplicado en las últimas 3 décadas. Dentro de sus complicaciones se encuentra la parálisis de cuerda vocal unilateral secundaria a lesión transitoria o permanente del nervio laríngeo recurrente, lo que se presenta clínicamente como disfonía. Caso clínico: Paciente de 58 años, post tiroidectomía total evoluciona con disfonía persistente. Videoestroboscopia evidencia parálisis cuerda vocal izquierda en posición paramediana, con hiato fonatorio longitudinal amplio. Se maneja con laringoplastía por inyección con ácido hialurónico a cuerda vocal paralítica, logrando mejora significativa de voz. En videoestroboscopia de control al 7º día se evidencia cuerda vocal izquierda en línea media, con borde libre recto, sin presencia de hiato al fonar. Conclusiones: La laringoplastía por inyección percutánea con ácido hialurónico es un procedimiento seguro y eficaz para el tratamiento de la disfonía secundaria a parálisis cordal unilateral post cirugía tiroidea.


الموضوعات
Humans , Female , Middle Aged , Hyaluronic Acid/administration & dosage , Laryngoscopy/methods , Vocal Cord Paralysis/surgery , Vocal Cord Paralysis/etiology , Thyroidectomy/adverse effects , Dysphonia/surgery , Dysphonia/etiology , Injections
15.
São Paulo med. j ; São Paulo med. j;133(1): 4-12, Jan-Fev/2015. tab, graf
مقالة ي الانجليزية | LILACS | ID: lil-733011

الملخص

CONTEXT AND OBJECTIVE: The development of a slow and progressive mechanical model for osteoarthritis is important for correlation with clinical practice, and for evaluating the effects of disease-modifying medications. A mechanical osteoarthritis model was developed to evaluate the effects of intra-articular hyaluronic acid (HA) injection and oral diacerein administration. DESIGN AND SETTING: Experimental study at the Department of Orthopedics and Traumatology, Universidade de São Paulo. METHOD: Total medial meniscectomy was performed on seven groups of ten Wistar rats each, comprising four control groups (C) and three study groups (S). C.I: operated, non-medicated; C.II: operated, injections of HA vehicle; C.III: non-operated, non-medicated; C.IV: operated, non-medicated, sacrificed three months post-meniscectomy; S.I: operated, receiving intra-articular HA injections; S.II: operated, oral diacerein from the third to the seventh postoperative month; S.III: operated, received both medications. All the animals (except C.IV) were sacrificed seven months post-meniscectomy. All femurs and tibias were assessed histologically. RESULTS: The most severe degenerative histological changes were in the tibias of the operated knees. On the contralateral side, all groups had mild changes on the tibial surface. The femoral surface had ...


CONTEXTO E OBJETIVO: Desenvolver um modelo osteoartrítico mecânico lento e progressivo é importante para correlação com a prática clínica e para avaliar os efeitos de medicamentos modificadores da doença. Um modelo mecânico de osteartrite foi desenvolvido para avaliar os efeitos de injeção intra-articular de hialuronato de sódio (AH) e de administração de diacereína oral. DESENHO E LOCAL: Estudo experimental no Departamento de Ortopedia e Traumatologia, Universidade de São Paulo. MÉTODO: Meniscectomia medial total foi feita em sete grupos de dez ratos Wistar, sendo quatro grupos controle (C) e três grupos estudo (E). C.I: operado, não medicado; C.II: operado, recebendo injeções do veículo do AH; C.III: não operado, não medicado; C.IV: operado, não medicado, sacrificado três meses pósmeniscectomia; EI: operado, recebendo injeções de AH intra-articular; E.II: operado, recebendo diacereína oral do terceiro ao sétimo mês pós-operatório; E.III: operado, recebeu ambas medicações. Todos os animais (exceto C.IV) foram sacrificados sete meses pós-meniscectomia. Todos os fêmures e tíbias foram analisados histologicamente. RESULTADOS: As alterações histológicas degenerativas ...


الموضوعات
Animals , Male , Anthraquinones/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Arthritis, Experimental/drug therapy , Hyaluronic Acid/administration & dosage , Menisci, Tibial/surgery , Osteoarthritis, Knee/drug therapy , Viscosupplements/administration & dosage , Administration, Oral , Arthritis, Experimental/etiology , Arthritis, Experimental/pathology , Disease Models, Animal , Disease Progression , Drug Therapy, Combination , Injections, Intra-Articular , Osteoarthritis, Knee/etiology , Osteoarthritis, Knee/pathology , Random Allocation , Rats, Wistar , Severity of Illness Index
16.
Korean J. Ophthalmol ; Korean J. Ophthalmol;: 131-137, 2015.
مقالة ي الانجليزية | WPRIM | ID: wpr-170373

الملخص

PURPOSE: To investigate the therapeutic effects of mineral oil (MO) and hyaluronic acid (HA) mixture eye drops on the tear film and ocular surface in a mouse model of experimental dry eye (EDE). METHODS: Eye drops consisting of 0.1% HA alone or mixed with 0.1%, 0.5%, or 5.0% MO were applied to desiccating stress-induced murine dry eyes. Tear volume, corneal irregularity score, tear film break-up time (TBUT), and corneal fluorescein staining scores were measured at 5 and 10 days after treatment. Ten days after treatment, goblet cells in the conjunctiva were counted after Periodic acid-Schiff staining. RESULTS: There was no significant difference in the tear volume between desiccating stress-induced groups. The corneal irregularity score was lower in the 0.5% MO group compared with the EDE and HA groups. The 0.5% and 5.0% MO groups showed a significant improvement in TBUT compared with the EDE group. Mice treated with 0.1% and 0.5% MO mixture eye drops showed a significant improvement in fluorescein staining scores compared with the EDE group and the HA group. The conjunctival goblet cell count was higher in the 0.5% MO group compared with the EDE group and HA group. CONCLUSIONS: The MO and HA mixture eye drops had a beneficial effect on the tear films and ocular surface of murine dry eye. The application of 0.5% MO and 0.1% HA mixture eye drops could improve corneal irregularity, the corneal fluorescein staining score, and conjunctival goblet cell count compared with 0.1% HA eye drops in the treatment of EDE.


الموضوعات
Animals , Female , Mice , Conjunctiva/drug effects , Cornea/metabolism , Disease Models, Animal , Drug Combinations , Dry Eye Syndromes/drug therapy , Emollients/administration & dosage , Goblet Cells/drug effects , Hyaluronic Acid/administration & dosage , Mice, Inbred C57BL , Mineral Oil/administration & dosage , Ophthalmic Solutions , Tears/metabolism , Viscosupplements/administration & dosage
17.
مقالة ي الانجليزية | WPRIM | ID: wpr-127325

الملخص

BACKGROUND: Septic arthritis of the knee has been reported recently in adult patients who were administered hyaluronate. We evaluated the incidence of septic knees and the utilization of hyaluronate in the Korean adult population using nationwide data from the Health Insurance Review and Assessment Service (HIRA). METHODS: All new admissions to the clinics or hospitals for septic knees were recorded in the HIRA database which was established by the Korean government and covers the Korean population using the International Classification of Diseases-10 revision code. We evaluated the incidence of septic arthritis of the knees in the population above 50 years of age. Hyaluronate prescription data was also collected from the HIRA database. RESULTS: In 2012, the incidence of septic knees was 2.7 per 100,000 persons in men and 4.2 per 100,000 persons in women, respectively. The age-adjusted incidence of septic knees increased by 6.7% per year (95% confidence interval, 3.3 to 10.1), and the annual number of prescriptions of hyaluronate increased about 1.5-fold during the study period. CONCLUSIONS: Cautious aseptic technique is required when hyaluronate is administered in adult patients with osteoarthritis of the knee due to the concerns of the risk of septic arthritis.


الموضوعات
Female , Humans , Male , Middle Aged , Arthritis, Infectious/epidemiology , Hyaluronic Acid/administration & dosage , Incidence , Injections, Intra-Articular/adverse effects , Knee Joint/physiopathology , Osteoarthritis, Knee/drug therapy , Republic of Korea/epidemiology
18.
Yonsei med. j ; Yonsei med. j;: 1379-1383, 2015.
مقالة ي الانجليزية | WPRIM | ID: wpr-39980

الملخص

PURPOSE: Osteoarthritic (OA) pain is largely considered to be inflammatory pain. However, during the last stage of knee OA, sensory nerve fibers in the knee are shown to be significantly damaged when the subchondral bone junction is destroyed, and this can induce neuropathic pain. Several authors have reported that tumor necrosis factor-alpha (TNFalpha) in a knee joint plays a crucial role in pain modulation. The purpose of the current study was to evaluate the efficacy of etanercept, a TNFalpha inhibitor, for pain in knee OA. MATERIALS AND METHODS: Thirty-nine patients with knee OA and a 2-4 Kellgren-Lawrence grading were evaluated in this prospective study. Patients were divided into two groups; hyaluronic acid (HA) and etanercept injection. All patients received a single injection into the knee. Pain scores were evaluated before and 4 weeks after injection using a visual analogue scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and they were compared between the groups. RESULTS: Before injection, VAS and WOMAC scores were not significantly different between the groups (p>0.05). Significant pain relief was found in the etanercept group at 1 and 2 weeks by VAS, and at 4 weeks by WOMAC score, compared with the HA group (p<0.05). No adverse events were observed in either group. CONCLUSION: Direct injection of etanercept into OA knee joints was an effective treatment for pain in moderate and severe OA patients. Furthermore, this finding suggests that TNFalpha is one factor that induces OA pain.


الموضوعات
Aged , Female , Humans , Male , Middle Aged , Etanercept/administration & dosage , Hyaluronic Acid/administration & dosage , Injections, Intra-Articular , Knee Joint/physiopathology , Neuralgia/drug therapy , Osteoarthritis, Knee/drug therapy , Pain Measurement , Prospective Studies , Severity of Illness Index , Treatment Outcome , Tumor Necrosis Factor-alpha , Viscosupplements/administration & dosage , Visual Analog Scale
19.
مقالة ي الانجليزية | WPRIM | ID: wpr-56489

الملخص

Cosmetic facial filler-related ophthalmic artery occlusion is rare but is a devastating complication, while the exact pathophysiology is still elusive. Cerebral angiography provides more detailed information on blood flow of ophthalmic artery as well as surrounding orbital area which cannot be covered by fundus fluorescein angiography. This study aimed to evaluate cerebral angiographic features of cosmetic facial filler-related ophthalmic artery occlusion patients. We retrospectively reviewed cerebral angiography of 7 patients (4 hyaluronic acid [HA] and 3 autologous fat-injected cases) showing ophthalmic artery and its branches occlusion after cosmetic facial filler injections, and underwent intra-arterial thrombolysis. On selective ophthalmic artery angiograms, all fat-injected patients showed a large filling defect on the proximal ophthalmic artery, whereas the HA-injected patients showed occlusion of the distal branches of the ophthalmic artery. Three HA-injected patients revealed diminished distal runoff of the internal maxillary and facial arteries, which clinically corresponded with skin necrosis. However, all fat-injected patients and one HA-injected patient who were immediately treated with subcutaneous hyaluronidase injection showed preserved distal runoff of the internal maxillary and facial arteries and mild skin problems. The size difference between injected materials seems to be associated with different angiographic findings. Autologous fat is more prone to obstruct proximal part of ophthalmic artery, whereas HA obstructs distal branches. In addition, hydrophilic and volume-expansion property of HA might exacerbate blood flow on injected area, which is also related to skin necrosis. Intra-arterial thrombolysis has a limited role in reconstituting blood flow or regaining vision in cosmetic facial filler-associated ophthalmic artery occlusions.


الموضوعات
Adult , Aged , Female , Humans , Young Adult , Adipose Tissue/transplantation , Arterial Occlusive Diseases/etiology , Cerebral Angiography , Cosmetic Techniques/adverse effects , Dermal Fillers/administration & dosage , Face , Hyaluronic Acid/administration & dosage , Hyaluronoglucosaminidase/administration & dosage , Injections, Subcutaneous , Ophthalmic Artery/diagnostic imaging , Retinal Artery Occlusion/etiology , Retrospective Studies , Transplantation, Autologous/adverse effects
20.
Int. j. morphol ; 32(4): 1199-1206, Dec. 2014. ilus
مقالة ي الأسبانية | LILACS | ID: lil-734659

الملخص

La osteoartrosis es un padecimiento del aparato locomotor con una prevalencia elevada y en crecimiento, paralela al envejecimiento de la población. La infiltración intraarticular de sustancias para aliviar la sintomatología de la osteoartrosis es una práctica común en el consultorio médico de los especialistas que atienden esta enfermedad. Aunque la sintomatología mejora con la infiltración de anestésicos locales, corticoesteroides y suplementos viscosantes, es aún incierto el efecto que estas sustancias tienen sobre la integridad del cartílago articular. Este estudio explora a nivel macroscópico e histológico el efecto de la infiltración de ropivacaína, metilprednisolona y ácido hialurónico sobre el cartílago articular en un modelo de osteoartrosis química en conejos (n=24). Nuestros resultados indican que en los grupos infiltrados con metilprednisolona (n=8) y ropivacaína (n=8) la estructura del cartílago articular presento alteraciones más severas con respecto a su grupo control, además de una disminución importante en la síntesis de matriz extracelular. En el grupo infiltrado con ácido hialurónico (n=8), las alteraciones macroscópicas e histológicas del cartílago articular mejoraron con respecto a su grupo control, presentando una estructura integra y síntesis de matriz extracelular normal.


Osteoarthritis is a musculoskeletal condition with a high prevalence, increasing with the aging of population. The intraarticular infiltration of substances to relieve the symptoms of osteoarthritis is a common practice in medical practice. Although symptoms improved with the infiltration of local anesthetics, corticosteroids and supplements, it is still uncertain what effect these substances have on the integrity of articular cartilage. This study explores the macroscopic and histological effects of infiltration of Ropivacaine, Methylprednisolone and Hyaluronic Acid on articular cartilage in a model of chemical osteoarthritis in rabbits (n=24). Our results indicate that in the infiltrated groups with Methylprednisolone (n=8) and Ropivacaine (n=8) the structure of articular cartilage present more severe alterations with respect to its control group and an important decrease in the synthesis of extracellular matrix. In-group infiltrated with hyaluronic acid (n=8), macroscopic and histological changes of articular cartilage improved with respect to its control group, presenting a normal structure and normal extracellular matrix synthesis.


الموضوعات
Animals , Male , Rabbits , Methylprednisolone/administration & dosage , Cartilage, Articular/drug effects , Cartilage, Articular/pathology , Osteoarthritis, Knee , Amides/administration & dosage , Hyaluronic Acid/administration & dosage , Methylprednisolone/pharmacology , Disease Models, Animal , Amides/pharmacology , Hyaluronic Acid/pharmacology
اختيار الاستشهادات
تفاصيل البحث